Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Quek RGW"'
Autor:
Ge W, Wu N, Jalbert JJ, Quek RGW, Liu J, Rietschel P, Pouliot JF, Harnett J, Hsu ML, Feliciano JL
Publikováno v:
Cancer Management and Research, Vol Volume 14, Pp 3191-3202 (2022)
Wenzhen Ge,1 Ning Wu,1 Jessica J Jalbert,1 Ruben GW Quek,1 Jinjie Liu,2 Petra Rietschel,1 Jean-Francois Pouliot,1 James Harnett,1 Melinda Laine Hsu,3 Josephine L Feliciano4 1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; 2Genesis Research, LLC,
Externí odkaz:
https://doaj.org/article/90206712e2c445ccb2ec248b86ba0be7
Publikováno v:
Clinical Epidemiology, Vol Volume 11, Pp 543-561 (2019)
Nigel Armstrong,1 Steve Ryder,1 Carol Forbes,2 Janine Ross,3 Ruben GW Quek41Health Economics, Kleijnen Systematic Reviews Ltd., York YO19 6FD, UK; 2Systematic Reviews, Kleijnen Systematic Reviews Ltd., York YO19 6FD, UK; 3Information, Kleijnen System
Externí odkaz:
https://doaj.org/article/6e6f863480b04438a8205d9e32d8aab8
Publikováno v:
Cancer Management and Research, Vol Volume 11, Pp 2321-2337 (2019)
Carol Forbes,1 Debra Fayter,1 Shelley de Kock,2 Ruben GW Quek3 1Department of Reviews, Kleijnen Systematic Reviews Ltd, Escrick, York YO19 6FD, UK; 2Department of Information, Kleijnen Systematic Reviews Ltd, Escrick, York YO19 6FD, UK; 3Health Econo
Externí odkaz:
https://doaj.org/article/d8f3aaedd8cc4d16a033412eae69f841
Publikováno v:
In Value in Health July 2022 25(7) Supplement:S388-S388
Publikováno v:
In Value in Health July 2022 25(7) Supplement:S505-S505
Autor:
Oderda G; College of Pharmacy, University of Utah, Salt Lake City., Brixner D; College of Pharmacy, University of Utah, Salt Lake City., Biskupiak J; College of Pharmacy, University of Utah, Salt Lake City., Harnett J; Regeneron Pharmaceuticals, Tarrytown, NY., Chen CI; Regeneron Pharmaceuticals, Tarrytown, NY., Quek RGW; Regeneron Pharmaceuticals, Tarrytown, NY.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Aug; Vol. 30 (8), pp. 825-833.
Autor:
Johnson PC; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Bailey A; Adelphi Real World, Adelphi Mill, Grimshaw Lane, Bollington, Macclesfield, Cheshire, SK10 5JB, UK., Ma Q; Health Economics and Outcomes Research, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Milloy N; Adelphi Real World, Adelphi Mill, Grimshaw Lane, Bollington, Macclesfield, Cheshire, SK10 5JB, UK. neil.milloy@adelphigroup.com., Biondi E; Adelphi Real World, Adelphi Mill, Grimshaw Lane, Bollington, Macclesfield, Cheshire, SK10 5JB, UK., Quek RGW; Health Economics and Outcomes Research, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Weatherby S; Adelphi Real World, Adelphi Mill, Grimshaw Lane, Bollington, Macclesfield, Cheshire, SK10 5JB, UK., Barlow S; Adelphi Real World, Adelphi Mill, Grimshaw Lane, Bollington, Macclesfield, Cheshire, SK10 5JB, UK.
Publikováno v:
Advances in therapy [Adv Ther] 2024 Aug; Vol. 41 (8), pp. 3342-3361. Date of Electronic Publication: 2024 Jul 08.
Autor:
Peris K; Catholic University Fondazione Policlinico Universitario-IRCCS, Rome, Italy., Inocencio TJ; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Stratigos AJ; National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece., Lewis KD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Eroglu Z; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Chang ALS; Dermatology Department, Stanford University School of Medicine, Redwood City, California, USA., Ivanescu C; IQVIA, Durham, North Carolina, USA., Sekulic A; Mayo Clinic, Scottsdale, Arizona, USA., Fury MG; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Chen CI; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Quek RGW; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Jul; Vol. 13 (14), pp. e7360.
Autor:
Baramidze A; Todua Clinic, Tbilisi, Georgia. Electronic address: baramidzeana@gmail.com., Makharadze T; LTD High Technology Hospital Med Center, Batumi, Georgia., Gogishvili M; High Technology Medical Centre, University Clinic Ltd, Tbilisi, Georgia., Melkadze T; Todua Clinic, Tbilisi, Georgia., Giorgadze D; Multiprofilie Clinic Consilium Medulla, Tbilisi, Georgia., Penkov K; Private Medical Institution Euromedservice, Saint Petersburg, Russia., Laktionov K; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow, Russia., Nemsadze G; The Institute of Clinical Oncology, Tbilisi, Georgia., Nechaeva M; Chelyabinsk Regional Clinical Oncology Center, Chelyabinsk, Russia., Rozhkova I; Kaluga Regional Clinical Oncology Dispensary, Kaluga, Russia., Kalinka E; Polish Mother's Memorial Hospital Research Institute, Łódź, Poland., Ag McIntyre D; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Perez J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Kaul M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Quek RGW; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Seebach F; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Rietschel P; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Pouliot JF; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Jul; Vol. 193, pp. 107821. Date of Electronic Publication: 2024 May 13.
Autor:
Johnson PC; Cancer Center, Massachusetts General Hospital, Boston, MA, United States., Bailey A; Adelphi Real World, Bollington, United Kingdom., Ma Q; Health Economics and Outcomes Research, Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Milloy N; Adelphi Real World, Bollington, United Kingdom., Butcher J; Adelphi Real World, Bollington, United Kingdom., Sanderson I; Adelphi Real World, Bollington, United Kingdom., Weatherby S; Adelphi Real World, Bollington, United Kingdom., Meadows R; Adelphi Real World, Bollington, United Kingdom., Quek RGW; Health Economics and Outcomes Research, Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Jun 24; Vol. 14, pp. 1402992. Date of Electronic Publication: 2024 Jun 24 (Print Publication: 2024).